Osteoprotegerin Is a Significant Prognostic Factor for Overall Survival in Patients With Primary Systemic Amyloidosis Independent of the Mayo Staging

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2015.07.483

Related search